Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 152
Filtrer
1.
Sci Rep ; 13(1): 18683, 2023 10 31.
Article de Anglais | MEDLINE | ID: mdl-37907574

RÉSUMÉ

The Vietnamese indica landrace 'Tetep' is known worldwide for its durable and broad spectrum-resistance to blast. We performed genetic and molecular analyses of leaf blast resistance in a Tetep derived recombinant inbred line 'RIL4' which is resistant to both leaf and neck blast. Phenotypic analysis of segregating F2 progenies suggested that leaf blast resistance in RIL4 was controlled by a dominant gene tentatively designated as Pi-l(t). The gene was mapped to a 2.4 cm region close to the centromere of chromosome 12. The search for the gene content in the equivalent genomic region of reference cv. Nipponbare revealed the presence of five NBS-LRR genes, two of which corresponded to the alleles of Pita and Pi67 genes previously identified from Tetep. The two other genes, LOC_Os12g17090, and LOC_Os12g17490 represented the homologs of stripe rust resistance gene Yr10. The allelic tests with Pita2 and Pi67 lines suggested that the leaf blast resistance gene in RIL4 is either allelic or tightly linked to these genes. The genomic position of the leaf blast resistance gene in RIL4 perfectly coincided with the genomic position of a neck blast resistance gene Pb2 previously identified from this line suggesting that the same gene confers resistance to leaf and neck blast. The present results were discussed in juxtaposition with past studies on the genes of Pita/Pita2 resistance gene complex.


Sujet(s)
Magnaporthe , Oryza , Cartographie chromosomique , Gènes de plante , Allèles , Feuilles de plante/génétique , Vietnam , Maladies des plantes/génétique , Oryza/génétique , Magnaporthe/génétique
2.
J Pediatric Infect Dis Soc ; 7(3): 253-256, 2018 Aug 17.
Article de Anglais | MEDLINE | ID: mdl-28992111

RÉSUMÉ

Here, we report a complex case that involved a pediatric patient who experienced recalcitrant multidrug-resistant Pseudomonas aeruginosa infection complicated by bacteremia/sepsis; our antibacterial options were limited because of resistance, allergies, and suboptimal source control. A cocktail of 2 bacteriophages targeting the infectious organism introduced on 2 separate occasions sterilized the bacteremia.


Sujet(s)
Bactériémie/thérapie , Phagothérapie , Infections à Pseudomonas/thérapie , Bactériémie/sang , Enfant d'âge préscolaire , Multirésistance bactérienne aux médicaments , Issue fatale , Humains , Mâle , Phagothérapie/effets indésirables , Phagothérapie/méthodes , Infections à Pseudomonas/sang
3.
Indian J Cancer ; 54(Supplement): S55-S64, 2017 Dec.
Article de Anglais | MEDLINE | ID: mdl-29292709

RÉSUMÉ

The epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of EGFR-mutant nonsmall cell lung cancer (NSCLC). These EGFR TKIs demonstrate a different adverse event (AE) profile as compared to conventional chemotherapy agents. They are more commonly associated with cutaneous AEs and diarrhea while hematological AEs occurred commonly with chemotherapy agents. These AEs are the extension of pharmacological effect and occur as a result of blockade of EGFR-regulated pathways in the skin and gastrointestinal tract. This review article sheds light on the safety profile of first-, second-, and third-generation EGFR TKIs based on data obtained from several clinical trials conducted in NSCLC patients and highlights trials comparing these agents with the conventional chemotherapy agents. The strategies to manage EGFR TKI-related AEs are also reviewed.


Sujet(s)
Effets secondaires indésirables des médicaments/anatomopathologie , Récepteurs ErbB/génétique , Tumeurs du poumon/traitement médicamenteux , Inhibiteurs de protéines kinases/effets indésirables , Diarrhée/induit chimiquement , Diarrhée/anatomopathologie , Résistance aux médicaments antinéoplasiques/génétique , Récepteurs ErbB/antagonistes et inhibiteurs , Humains , Tumeurs du poumon/génétique , Tumeurs du poumon/anatomopathologie , Mutation , Inhibiteurs de protéines kinases/usage thérapeutique , Maladies de la peau/induit chimiquement , Maladies de la peau/anatomopathologie
4.
Zootaxa ; 4208(3): zootaxa.4208.3.6, 2016 Dec 16.
Article de Anglais | MEDLINE | ID: mdl-27988527

RÉSUMÉ

A new species from India, Physomerus centralis sp. nov. (Hemiptera: Heteroptera: Coreidae) is described and illustrated with both male and female genitalia. Morphological measurements and their ratios were taken as additional diagnostic characters. A key to the Indian species of the genus Physomerus Burmeister is provided.


Sujet(s)
Heteroptera/anatomie et histologie , Heteroptera/classification , Répartition des animaux , Animaux , Femelle , Inde , Mâle , Spécificité d'espèce
5.
Indian J Cancer ; 53(1): 109-12, 2016.
Article de Anglais | MEDLINE | ID: mdl-27146755

RÉSUMÉ

OBJECTIVES: Primitive neuroectodermal tumors (PNET) are rare highly aggressive neoplasms. The diagnosis is made by histopathology with the support of immunohistochemistry (IHC) and cytogenetics. The aggressive multimodality treatment is recommended for the management of these tumors. The purpose of our study is to review our experiences in the diagnoses and treatment of PNET of the kidneys. MATERIALS AND METHODS: We retrospectively reviewed the data of all the patients, who were treated for the PNET of the kidneys at our institute between April and March 2011 and compared with the available literature. RESULTS: A total of eight patients were treated for PNET of the kidney. Out of the eight patients, four were males and four females. Nearly 50% of our patients had inferior vena caval thrombus at the time of presentation. The diagnosis was made on histopathology supported by IHC. Out of the eight patients, one patient had intraoperative death due to massive pulmonary thromboembolism and another died on the 7th post-operative day due to disseminated intravascular coagulation and multiorgan failure. Rest six patients were treated with post-operative chemotherapy or a combination of chemotherapy and radiotherapy. For these six patients, overall median survival was 45 months with a 3 year disease-free survival of 66% and 5 year survival of 44%. CONCLUSIONS: PNET of the kidneys are rare peripheral neuroectodermal tumors with an aggressive clinical course. These tumors carry a very poor prognosis. An aggressive treatment approach using a combination of surgery, chemotherapy and radiotherapy is recommended for a reasonable survival in these tumors.


Sujet(s)
Tumeurs du rein/diagnostic , Tumeurs du rein/thérapie , Tumeurs neuroectodermiques primitives/diagnostic , Tumeurs neuroectodermiques primitives/thérapie , Adulte , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Chimioradiothérapie , Traitement médicamenteux adjuvant , Femelle , Humains , Tumeurs du rein/anatomopathologie , Mâle , Adulte d'âge moyen , Néphrectomie , Tumeurs neuroectodermiques primitives/anatomopathologie , Études rétrospectives , Centres de soins tertiaires , Jeune adulte
6.
Zootaxa ; 3904(1): 116-22, 2015 Jan 05.
Article de Anglais | MEDLINE | ID: mdl-25660775

RÉSUMÉ

A new species of Stenolemus Signoret, 1858, Stenolemus annulatus sp. nov. (Reduviidae: Emesinae) is described from India. This new species is closely related to S. susainathani Wygodzinsky from Nilgiri Hills, South India and S. larat Wygodzinsky from Moluccas, Larat, by sharing common characteristics such as the ratio of distance between eyes and their width, long antennal first segment, slightly elevated postocular region of head and sharply divided pronotum into three parts, but can be easily separated by the following diagnostic characteristics: pronotum with petiole about as long as forelobe and 1.3 times shorter than hindlobe, first antennal segment with five annulations, rostrum creamy white and luteous at apex, basal and lateral areas of second segment; hind lobe of pronotum with 1+1 submedian conical rounded projections; forecoxa shorter than hind lobe of pronotum, foretibia with one subbasal and one submedian annulation and hind femora reaching apex of forewings. A key to Indian species of the genus Stenolemus is given. 


Sujet(s)
Reduviidae/classification , Répartition des animaux , Structures anatomiques de l'animal/anatomie et histologie , Structures anatomiques de l'animal/croissance et développement , Animaux , Mensurations corporelles , Écosystème , Femelle , Inde , Mâle , Taille d'organe , Reduviidae/anatomie et histologie , Reduviidae/croissance et développement
7.
Andrology ; 3(2): 368-75, 2015 Mar.
Article de Anglais | MEDLINE | ID: mdl-25675950

RÉSUMÉ

Escherichia coli (E. coli) is a common pathogen in epididymitis, which represents a prevalent entity in male reproductive tract infections (RTI). Although current treatment regimens using antibiotics are satisfactory, development of antimicrobial resistance by the pathogen represents a challenge in the management of RTI. Hence, identification of antimicrobial peptides as alternatives to antibiotics has gained importance. We demonstrate that in a rat epididymo-orchitis model induced with uropathogenic E. coli (UPEC) strain MTCC 729, the expression of defensins and defensin-like Spag11 genes are induced in the epididymis and testes. The induction of antimicrobial gene expression is paralleled by phosphorylation of the NF-kB subunit p65 and the inhibitor of NFkB (IkB-alpha), decreased levels of histone deacetylase 1 and increased methylation of Histone 3, indicating the role of classical Toll-like receptor mediated signaling and epigenetic regulation. Recombinant Defensin 21, when administered to UPEC-infected rats, substantially reduced the bacterial load in the epididymis and testis and proved to be more effective than gentamycin. The ability of Defensin 21 to limit RTI provides support that antibacterial proteins of the male reproductive tract may be used as potential alternatives to antibiotics in treatment of this disease.


Sujet(s)
Défensines/métabolisme , Expression des gènes , Système génital de l'homme/métabolisme , Escherichia coli uropathogène/pathogénicité , Animaux , Mâle , Rats , Rat Wistar
8.
Clin Oncol (R Coll Radiol) ; 26(11): 722-9, 2014 Nov.
Article de Anglais | MEDLINE | ID: mdl-24919857

RÉSUMÉ

AIMS: Data on metastatic Ewing's sarcoma family of tumours (ESFT) with uniform chemotherapy protocol are minimal. MATERIALS AND METHODS: This was a single institutional patient review of patients treated between June 2003 and November 2011 and evaluated on an intent-to-treat analysis. All patients received uniform chemotherapy: neoadjuvant chemotherapy (NACT), surgery and/or radiotherapy as local treatment followed by adjuvant chemotherapy. Local treatment was offered if the patient achieved a complete response and/or a partial response at both the primary and the metastatic site. RESULTS: In total, 150/374 (40%) ESFT patients were metastatic, with a median age of 15 years (range: 2-50); a tumour diameter of 10 cm (range: 1.8-26). Most common metastatic sites were lung only (53; 35%), bone only (35; 23%) and combined bone/lung (25; 17%). Twenty patients underwent surgery; 55 patients received radical radiotherapy after NACT. After a median follow-up of 26.1 months (range: 1.6-101.6), 5 year event-free survival (EFS), overall survival and local control rate (LCR) were 9.1 ± 3.3%, 16.9 ± 5.2% and 31.8 ± 7.9%, respectively. Univariate analysis showed serum albumin ≤3.4 g/dl (P < 0.001) to predict inferior EFS. Tumour size >8 cm (P = 0.05), haemoglobin ≤10 g/dl (P = 0.04), hypoalbuminaemia (P = 0.003) and radical radiotherapy as local treatment (P = 0.03) predicted inferior overall survival. No factor significantly predicted LCR, although age ≤15 years (P = 0.08) and radical radiotherapy as local treatment (P = 0.09) had a trend towards inferior LCR. Hypoalbuminaemia was the only prognostic factor to predict EFS on multivariate analysis. CONCLUSION: This was the largest study of metastatic ESFT from Asia and identified a unique prognostic factor. In view of dismal prognosis with conventional chemotherapy in metastatic ESFT with hypoalbuminaemia, palliative intent therapy may be a potential therapeutic alternative for this subgroup of patients, especially in resource-challenged situations.


Sujet(s)
Protocoles de polychimiothérapie antinéoplasique/effets indésirables , Tumeurs de la moelle osseuse/traitement médicamenteux , Tumeurs osseuses/traitement médicamenteux , Hypoalbuminémie/mortalité , Tumeurs du poumon/traitement médicamenteux , Traitement néoadjuvant/effets indésirables , Sarcome d'Ewing/traitement médicamenteux , Adolescent , Adulte , Tumeurs de la moelle osseuse/mortalité , Tumeurs de la moelle osseuse/secondaire , Tumeurs osseuses/mortalité , Tumeurs osseuses/secondaire , Enfant , Enfant d'âge préscolaire , Femelle , Études de suivi , Humains , Hypoalbuminémie/induit chimiquement , Tumeurs du poumon/mortalité , Tumeurs du poumon/secondaire , Mâle , Adulte d'âge moyen , Stadification tumorale , Pronostic , Études prospectives , Sarcome d'Ewing/mortalité , Sarcome d'Ewing/anatomopathologie , Taux de survie , Jeune adulte
9.
J HIV AIDS Soc Serv ; 13(1): 8-25, 2014 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-24678283

RÉSUMÉ

Antiretroviral therapy (ART) has changed HIV related illness from terminal to chronic by suppressing viral load which results in immunologic and clinical improvement. Success with ART is dependent on optimal adherence, commonly categorized as >95%. As medication type, class and frequency of use continue to evolve, we assessed adherence levels related to viral suppression. Using a cross-sectional analysis with secondary data (n = 381) from an ongoing multi-site study on impact of ART on the Central Nervous System (CNS), we compared self-reported adherence rates with biological outcomes of HIV-RNA copies/ml, and CD4 cell/mm3. Adherence to ART measures included taking all prescribed medication as directed on schedule and following dietary restrictions. While depression was a barrier to adherence, undetectable viral suppression was achieved at pill adherence percentages lower than 95%. Practice, research and policy implications are discussed in the context of patient-, provider-, and system-level factors influencing adherence to ART.

10.
Rev Sci Instrum ; 84(10): 103301, 2013 Oct.
Article de Anglais | MEDLINE | ID: mdl-24182101

RÉSUMÉ

A solenoid magnetic field model is presented that describes the on axis field by a parameter of its hard edginess and axial half-width at half-maximum field, which universally define its spherical aberration without solving the ray equation. The model shows an increase in spherical aberration from real soft edge fields to hard edge models, as used in beam tracking. It compares well with existing field models. It simply and accurately finds the spherical aberration in many types of solenoids.

11.
Int J Obstet Anesth ; 22(4): 316-21, 2013 Nov.
Article de Anglais | MEDLINE | ID: mdl-23962470

RÉSUMÉ

BACKGROUND: Intrathecal tramadol combined with local anaesthetics has been used for postoperative analgesia following lower abdominal and perineal surgery. The present study evaluated the effect of intrathecal tramadol on spinal block characteristics and neonatal outcome after elective caesarean section. METHODS: Eighty full-term parturients scheduled for elective caesarean section were randomly divided into two groups. In the fentanyl group, patients received intrathecal 0.5% bupivacaine 10 mg with fentanyl 10 µg; in the tramadol group, patients were given the same dose of bupivacaine with tramadol 10 mg. Sensory and motor block characteristics, duration of postoperative analgesia, maternal side effects, and neonatal outcome were compared. RESULTS: One patient in the tramadol group and two patients in the fentanyl group were excluded from data analysis. Median [interquartile range] duration of postoperative analgesia in the tramadol and the fentanyl groups was 300 [240-360] min and 260 [233-300] min respectively (P = 0.02). The incidence of shivering was lower in patients who received tramadol (5%) than those who had fentanyl (32%) (P = 0.003). Apgar scores, umbilical cord acid-base measurement and neurologic and adaptive capacity scores were comparable between the two groups. CONCLUSION: Compared to intrathecal fentanyl 10 µg, tramadol 10 mg, as an adjunct to bupivacaine for subarachnoid block for caesarean section, showed a longer duration of analgesia with a reduced incidence of shivering.


Sujet(s)
Analgésiques morphiniques/administration et posologie , Anesthésie obstétricale/méthodes , Rachianesthésie/méthodes , Césarienne , Tramadol/administration et posologie , Adulte , Score d'Apgar , Méthode en double aveugle , Femelle , Fentanyl/administration et posologie , Humains , Nouveau-né , Injections rachidiennes , Grossesse , Tramadol/effets indésirables
12.
Kathmandu Univ Med J (KUMJ) ; 10(38): 41-5, 2012.
Article de Anglais | MEDLINE | ID: mdl-23132474

RÉSUMÉ

BACKGROUND: Postoperative nausea and vomiting is a common distressing problem in patients undergoing gynaecological surgery under anaesthesia including central neuraxial blockade, which requires frequent medical interventions. OBJECTIVES: We aimed to find out the antiemetic effect of prophylactic dexamethasone for prevention of postoperative nausea and vomiting in patients undergoing total abdominal hysterectomy under subarachnoid block. Influences of dexamethasone on patient satisfaction and postoperative analgesia were also observed as secondary objectives. METHODS: This was a prospective, randomized, double blind, placebo controlled study conducted in BPKIHS, from January 2009 to April 2009. This study involved 80 American Society of Anaesthesiologist Physical Status I and II patients undergoing total abdominal hysterectomy under subarachnoid block. Patients were divided into two groups of 40 each to receive either 4 mg of dexamethasone (group D) or normal saline (group N) in volume of 2 ml intravenously 1 hour prior to subarachnoid block. Surgery was allowed to start with block height of at least T8 dermatome. Intraoperative and postoperative nausea and vomiting was observed using nausea and vomiting scale every 4 hour for 24 hours. RESULTS: Seven (17.4%) patients in group D and 11 (27.5%) patients in group N had nausea and vomiting in the intraoperative period (P=0.284). Sixteen (40%) patients in group D experienced nausea and vomiting in the postoperative period as compared to 27 (67.5%) in group N (P =0.0136). Accordingly, the mean requirement of rescue antiemetic was less in group D compared to Group N (P=0.042). Further, only 15 (37.5%) patients in group D required postoperative supplemental analgesic as compared to 23 (57.5%) in group N (P=0.058). After 24 hrs of surgery, 26 (65%) patients expressed satisfaction in group D as compared to 16 (40.0%) in group N (P =0.025). CONCLUSIONS: Use of dexamethasone prior to subarachnoid block in patients undergoing total abdominal hysterectomy significantly reduces the incidence of nausea and vomiting and the requirement of antiemetic in the postoperative period, with better patient satisfaction.


Sujet(s)
Antiémétiques/usage thérapeutique , Dexaméthasone/usage thérapeutique , Hystérectomie , Bloc nerveux/effets indésirables , Vomissements et nausées postopératoires/prévention et contrôle , Adulte , Méthode en double aveugle , Femelle , Humains , Adulte d'âge moyen , Études prospectives , Espace sous-arachnoïdien
13.
Lupus ; 21(5): 517-25, 2012 Apr.
Article de Anglais | MEDLINE | ID: mdl-22247341

RÉSUMÉ

Membrane cofactor protein (MCP) is a complement regulatory protein ubiquitously expressed on most nucleated cells. Since MCP protects autologous cells from complement-mediated injury, it is suggested to have a protective role against the self-tissue damage in inflammatory conditions such as systemic lupus erythematosus (SLE). However, the relevance of MCP in human SLE is not well explored. To assess the significance of MCP in SLE, we studied expression of leukocyte MCP transcript in 60 healthy individuals (controls) and 60 patients with SLE and correlated that with the levels of circulating immune complex (CIC), C3, C3d and SLEDAI scores. The levels of leukocyte MCP transcript were significantly higher (p < 0.001) in patients with SLE than the controls. Furthermore, MCP transcript levels exhibited significant positive correlations with SLEDAI scores and CIC level and a negative correlation with C3d level in patients. Twelve patients were followed-up until remission. The levels of MCP transcripts decreased significantly during remission as compared with the state of active disease. These findings suggest that in SLE, the expression of leukocyte MCP at the mRNA level is closely related to disease activity. A protective role of MCP in response to increased disease burden may be speculated. The follow-up study suggested MCP as a potential disease marker.


Sujet(s)
Régulation de l'expression des gènes , Leucocytes/immunologie , Lupus érythémateux disséminé/immunologie , Antigènes CD46/génétique , Adulte , Études cas-témoins , Femelle , Études de suivi , Prédisposition génétique à une maladie , Humains , Lupus érythémateux disséminé/physiopathologie , Mâle , Indice de gravité de la maladie , Jeune adulte
14.
J Obstet Gynaecol India ; 62(4): 419-23, 2012 Aug.
Article de Anglais | MEDLINE | ID: mdl-23904702

RÉSUMÉ

OBJECTIVES: The objective of this study was to evaluate the efficacy and safety of granisetron (5HT3 receptor antagonist) on the incidence of nausea and vomiting in cesarean deliveries under spinal anesthesia. METHODS: In the randomized, double-blind study, 80 parturients received granisetron 40 µg/kg or placebo (n = 40 each) intravenously, immediately after clamping of the fetal umbilical cord. Nausea, vomiting, and adverse events were then observed for 24 h after administration of spinal anesthesia. RESULTS: A complete response (defined as no postoperative nausea and vomiting) during 0-4 h after administration of spinal anesthesia was achieved in 80 % of patients with granisetron and in 45 % of patients with placebo. The corresponding incidences during (4-24 h) were 82.5 and 55 % (P value <0.05). No difference in adverse events was observed in any of the groups. CONCLUSIONS: Prophylactic use of granisetron is effective for preventing emetic episodes during spinal anesthesia for cesarean delivery.

16.
Gut ; 59(11): 1476-84, 2010 Nov.
Article de Anglais | MEDLINE | ID: mdl-20947883

RÉSUMÉ

BACKGROUND AND AIMS: The intestinal microbiota plays a critical role in maintaining human health; however, the mechanisms governing the normal homeostatic number and composition of these microbes are largely unknown. Previously it was shown that intestinal alkaline phosphatase (IAP), a small intestinal brush border enzyme, functions as a gut mucosal defence factor limiting the translocation of gut bacteria to mesenteric lymph nodes. In this study the role of IAP in the preservation of the normal homeostasis of the gut microbiota was investigated. METHODS: Bacterial culture was performed in aerobic and anaerobic conditions to quantify the number of bacteria in the stools of wild-type (WT) and IAP knockout (IAP-KO) C57BL/6 mice. Terminal restriction fragment length polymorphism, phylogenetic analyses and quantitative real-time PCR of subphylum-specific bacterial 16S rRNA genes were used to determine the compositional profiles of microbiotas. Oral supplementation of calf IAP (cIAP) was used to determine its effects on the recovery of commensal gut microbiota after antibiotic treatment and also on the colonisation of pathogenic bacteria. RESULTS: IAP-KO mice had dramatically fewer and also different types of aerobic and anaerobic microbes in their stools compared with WT mice. Oral supplementation of IAP favoured the growth of commensal bacteria, enhanced restoration of gut microbiota lost due to antibiotic treatment and inhibited the growth of a pathogenic bacterium (Salmonella typhimurium). CONCLUSIONS: IAP is involved in the maintenance of normal gut microbial homeostasis and may have therapeutic potential against dysbiosis and pathogenic infections.


Sujet(s)
Phosphatase alcaline/physiologie , Intestin grêle/enzymologie , Intestin grêle/microbiologie , Métagénome/physiologie , Administration par voie orale , Phosphatase alcaline/déficit , Phosphatase alcaline/pharmacologie , Animaux , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/isolement et purification , Fèces/microbiologie , Bactéries aérobies à Gram négatif/isolement et purification , Bactéries anaérobies à Gram négatif/isolement et purification , Homéostasie/physiologie , Métagénome/effets des médicaments et des substances chimiques , Souris , Souris de lignée C57BL , Souris knockout , Phylogenèse , Polymorphisme de restriction , ARN bactérien/génétique , ARN ribosomique 16S/génétique , Salmonella typhimurium/effets des médicaments et des substances chimiques , Salmonella typhimurium/croissance et développement
17.
J Appl Microbiol ; 108(2): 658-65, 2010 Feb.
Article de Anglais | MEDLINE | ID: mdl-19796127

RÉSUMÉ

AIMS: To (i) study the serogroup distribution and virulence characteristics of non-sorbitol-fermenting Escherichia coli isolates from foods of animal origin and cattle faeces and (ii) re-examine the true sorbitol and beta-D-glucuronidase (GUD) reactions of sorbitol-negative (Sor(-)) strains from MacConkey sorbitol agar (SMAC) to assess their phenotypic similarity with E. coli O157. METHODS AND RESULTS: One hundred and thirty Sor(-)E. coli were isolated from 556 food samples and 177 cattle stool samples using cefixime tellurite-supplemented SMAC (CT-SMAC) and chromogenic HiCrome MS.O157 agar respectively. Based on typing of somatic antigen, the isolates were classified into 38 serogroups. PCR results identified about 40% strains, belonging to O5, O8, O20, O28, O48, O60, O78, O82, O84, O101, O110, O123, O132, O156, O157, O-rough and OUT as Shiga toxigenic. Majority of O5, O84, O101, O105, O123, O157, O-rough and OUT strains were enterohaemolytic. Further, 39.2% and 63.1% of Sor(-) isolates from CT-SMAC fermented sorbitol in phenol red broth and hydrolysed 4-methylumbelliferyl-beta-D-glucuronide (MUG) respectively. Members of serogroups O5, O28, O32, O81, O82, O84, O101, O-rough lacked both the sorbitol fermentation (broth test) and GUD activity and might create confusion in phenotypic identification of E. coli O157. CONCLUSIONS: Sor(-)E. coli isolates from raw meat, milk, shrimp and cattle stool belonged to 38 serogroups, with E. coli O157 constituting only 14.6% of the isolates. Many of these nonclinical Sor(-) strains were potentially pathogenic. Nearly 39% of these Sor(-)E. coli from CT-SMAC fermented sorbitol in broth, indicating the need for confirmation of sorbitol reaction in broth. SIGNIFICANCE AND IMPACTS OF THE STUDY: Classical sorbitol utilization and GUD tests are not likely definitive tests for E. coli O157. Further improvement of differential media based on these phenotypic properties is necessary for detection of pathogenic serotypes from foods and environmental samples.


Sujet(s)
Escherichia coli/classification , Fèces/microbiologie , Contamination des aliments , Microbiologie alimentaire , Animaux , Bovins , Milieux de culture , Escherichia coli/isolement et purification , Escherichia coli/pathogénicité , Hymécromone/analogues et dérivés , Hymécromone/métabolisme , Viande/microbiologie , Lait/microbiologie , Sérotypie , Sorbitol/métabolisme , Virulence
18.
Rural Remote Health ; 9(1): 926, 2009.
Article de Anglais | MEDLINE | ID: mdl-19260766

RÉSUMÉ

INTRODUCTION: This record-based study was undertaken at Bagula Tuberculosis Unit, Nadia, West Bengal, India to compare outcomes among sputum-positive TB retreatment patient groups (relapse, failure and treatment after default) at completion of therapy, under the Revised National Tuberculosis Control Program (RNTCP). METHODS: A total of 234 registered cases of TB retreatment (category II) between January 1999 and June 2005 were analysed and compared by Z-test for proportion. RESULTS: There was a uniform distribution in terms of age, grades of sputum positivity and sputum conversion at 2 and 3 months among the three groups. In spite of this, a favourable outcome was most likely for relapse cases, and cases with a low grade of sputum positivity in all three subgroups. Unfavourable outcome was most likely among the treatment failure subgroup and those with high grades of sputum positivity. CONCLUSION: The results are likely to be due to an increased incidence of multi-drug resistant TB in these patients. In rural areas of the developing world, as in India, there is a heavy burden of TB and resources are limited. Culture and drug sensitivity patterns prior to commencing therapy should be performed for failure and default patients who present with an initially high load of bacilli in their sputum.


Sujet(s)
Antituberculeux/usage thérapeutique , Services de santé ruraux , Santé en zone rurale , Expectoration/microbiologie , Tuberculose pulmonaire/traitement médicamenteux , Adulte , Contrôle des maladies transmissibles , Pays en voie de développement , Calendrier d'administration des médicaments , Association de médicaments , Humains , Incidence , Inde/épidémiologie , Tests de sensibilité microbienne , Programmes nationaux de santé , Sélection de patients , Guides de bonnes pratiques cliniques comme sujet , Reprise du traitement , Études rétrospectives , Santé en zone rurale/statistiques et données numériques , Résultat thérapeutique , Tuberculose multirésistante/épidémiologie , Tuberculose pulmonaire/classification , Tuberculose pulmonaire/diagnostic , Tuberculose pulmonaire/épidémiologie , Tuberculose pulmonaire/microbiologie
19.
Nepal Med Coll J ; 10(1): 16-9, 2008 Mar.
Article de Anglais | MEDLINE | ID: mdl-18700624

RÉSUMÉ

The present study compared the efficacy of preloading with colloid "Haemaccel" with vasoconstrictor (intravenous ephedrine sulphate) in preventing hypotension during propofol induction. This prospective, randomized study included 120 patients of Amercan Society of Anaesthesiologists (ASA) physical status I and II ageing 21 to 50 years of both gender coming for routine surgery. Patients were randomly allocated into three groups with 40 patients in each. Group A (control) did not receive any study medication, group B received Haemaccel (10 ml/kg intravenously over 10-15 minutes) and group C received injection ephedrine (0.2 mg/kg iv) prior to induction of anaesthesia. Propofol (2.5 mg/kg iv) was used for induction of anaesthesia. Heart rate and blood pressure were recorded before induction (baseline) and then every minute for 5 minutes after administering propofol. Anaesthesia was continued with standard technique thereafter. Hypotension was defined as fall in systolic blood pressure more than 20% from the basal value. The incidence of hypotension in Haemaccel (23.1%) or ephedrine group (22.5%) was significantly less than the control group (67.5%, P<0.01). We conclude that though preloading with colloid (Haemaccel) or prior injection of sympathomimetic (ephedrine) are not fully efficacious in preventing hypotension caused by propofol induction, both decrease the incidence in significant number of patients with heart rate less than baseline value in the colloid group.


Sujet(s)
Anesthésie , Anesthésiques intraveineux/effets indésirables , Éphédrine/administration et posologie , Hypotension artérielle/prévention et contrôle , Substituts du plasma/administration et posologie , Polygéline/administration et posologie , Propofol/effets indésirables , Vasoconstricteurs/administration et posologie , Adulte , Femelle , Humains , Hypotension artérielle/induit chimiquement , Perfusions veineuses , Injections veineuses , Mâle , Adulte d'âge moyen
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE